**Chapter 16**

*Genetic Variation*

2009;36(9):1873-1875.

2014;33(6):791-797.

2015;74(9):1659-1666.

[47] Youssef W, Yan A, Russell AS. Palindromic rheumatism: a response to chloroquine. The Journal of rheumatology. 1991;18(1):35-37.

[48] Gonzalez-Lopez L, Gamez-Nava JI, Jhangri G, Russell AS, Suarez-Almazor ME. Decreased progression to rheumatoid arthritis or other connective

tissue diseases in patients with palindromic rheumatism treated with antimalarials. Journal of rheumatology.

[49] Edwards JC, Szczepański L, Szechiński J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B-cell–targeted therapy with rituximab in patients with rheumatoid arthritis. New England Journal of Medicine.

2004;350(25):2572-2581.

2000;27(1):41-46.

outcomes of 60 patients diagnosed in 1967-84. The Journal of rheumatology. [50] Van Vollenhoven RF,

2012;367(6):508-519.

traditional herbs. 2017.

Research. 2017;9(5):547.

[51] Nighojkar PA, Momin M, Phadatare SP. Rheumatoid arthritis– Pharmacology and its management with

[52] Zarei L, Naji-Haddadi S, Pourjabali M, Naghdi N, Tasbih-Forosh M, Shahsavari S. Systematic review of anti-rheumatic medicinal plants: An overview of the effectiveness of articular tissues and joint pain associated with rheumatoid arthritis. Journal of Pharmaceutical Sciences and

Fleischmann R, Cohen S, Lee EB, García Meijide JA, Wagner S, et al. Tofacitinib or adalimumab versus placebo in rheumatoid arthritis. New England Journal of Medicine.

[44] Emad Y, Anbar A, Abo-Elyoun I,

[45] Sanmartí R, Cabrera-Villalba S, Gómez-Puerta JA, Ruiz-Esquide V, Hernández MV, Salvador G, et al. Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study. The Journal of

rheumatology. 2012;39(10):1929-1933.

[46] Rakieh C, Nam J, Hunt L, Hensor E, Das S, Bissell L, et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with nonspecific musculoskeletal symptoms: a prospective observational cohort study. Annals of the rheumatic diseases.

El-Shaarawy N, Al-Hanafi H, Darwish H, et al. In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up. Clinical rheumatology.

**272**
